Clinical Trials Browser

Leukemia, Myeloid × Temozolomide × Clear all

NCT00611247 2018-06-15

Phase 2 Study of Temozolomide to Treat Poor Risk / Refractory Acute Myeloid Leukemia

Phase 2 Completed

42 enrolled 8 charts

Other hematologic neoplasm

Leukemia, Myeloid